807PFirst interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza). (18th September 2017) - Harshman, L.C.; Logue, J.; Sternberg, C.N.; Sundar, S.; Schrijvers, D.; Schostak, M.; Sylvester, J.; George, S.; Tucci, M.; Mantz, C.; Borrega, P.; Ziem, P.; et al.